Join to View Full Profile
100 E 77th StNew York, NY 10075
Phone+1 212-434-2000
Dr. Bergagnini is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalFellowship, Gastroenterology, 2021 - 2024- Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalChief Residency, Internal Medicine, 2020 - 2021
- Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalResidency, Internal Medicine, 2017 - 2020
NYIT College Of Osteopathic MedicineClass of 2017- New York UniversityBA, Spanish & Linguistics , 2005 - 2009
Certifications & Licensure
NY State License 2020 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
American Board of Obesity Medicine Obesity Medicine
Awards, Honors, & Recognition
- Iris and Saul Katz Innovations Grant Northwell Health, 2022
Publications & Presentations
PubMed
- 237 citationsPD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers.Joshua K. Sabari, Giulia Costanza Leonardi, Catherine A. Shu, Renato Umeton, Joseph Montecalvo
Annals of Oncology. 2018-10-01 - 39 citationsThe activity, safety, and evolving role of brigatinib in patients with ALK -rearranged non-small cell lung cancers.Joshua K. Sabari, Fernando C. Santini, Alison M. Schram, Isabella Bergagnini, Ruqin Chen
Oncotargets and Therapy. 2017-04-06 - 90 citationsClinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancers.A. Drilon, Isabella Bergagnini, Lukas Delasos, Joshua K. Sabari, Kaitlin M. Woo
Annals of Oncology. 2016-04-07
Journal Articles
- PD-L1 Expression, Tumor Mutational Burden, and Response to Immunotherapy in Patients with MET Exon 14 Altered Lung CancersG J Riely, J Dienstag, C Mrad, J K Sabari, M G Kris, K C Arbour, D F Halpenny, N Rekhtman, R Chen, A J Plodkowski, P K Paik, B T Li, I Bergagnini, M D Offin, C M Rudin..., Annals of Oncology
Press Mentions
AI in Colonoscopy: Disconnect Grows Between Academic, Community StudiesMay 9th, 2023
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
